MicroRNA-mediated mechanisms of the cellular stress response in atherosclerosis

Nature Reviews Cardiology

Volumn 12, Issue 6, 2015, Pages 361-374

  Schober, Andreas ^a   Nazari Jahantigh, Maliheh ^a   Weber, Christian ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 10A; MICRORNA 181B; MICRORNA 19A; MICRORNA 205; MICRORNA 21; MICRORNA 217; MICRORNA 34; MICRORNA 712; MICRORNA 92A; UNCLASSIFIED DRUG;

ATHEROGENESIS; ATHEROSCLEROSIS; CELL ACTIVATION; CELL COMMUNICATION; CELL FUNCTION; CELL KINETICS; CELL PROLIFERATION; CELL REGENERATION; CELL TRANSFER; CELLULAR STRESS RESPONSE; CHOLESTEROL METABOLISM; ENDOTHELIUM CELL; ENDOTHELIUM INJURY; GENE ACTIVATION; GENE CONTROL; GENETIC TRANSCRIPTION; HEMODYNAMICS; HUMAN; HYPERLIPIDEMIA; LIPID STORAGE; MACROPHAGE; MACROPHAGE FUNCTION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SHEAR STRESS; UNFOLDED PROTEIN RESPONSE; BLOOD RHEOLOGY; COMPLICATION; GENE EXPRESSION REGULATION; GENETICS; MECHANOTRANSDUCTION; PATHOPHYSIOLOGY; PHYSIOLOGY; VASCULAR ENDOTHELIUM;

ATHEROSCLEROSIS; ENDOTHELIUM, VASCULAR; GENE EXPRESSION REGULATION; HEMODYNAMICS; HEMORHEOLOGY; HUMANS; HYPERLIPIDEMIAS; MACROPHAGES; MECHANOTRANSDUCTION, CELLULAR; MICRORNAS;

EID: 84929957883     PISSN: 17595002     EISSN: 17595010     Source Type: Journal    
DOI: 10.1038/nrcardio.2015.38     Document Type: Review

References (192)

1. Strong, J. P. et al. Prevalence and extent of atherosclerosis in adolescents and young adults: implications for prevention from the Pathobiological Determinants of Atherosclerosis in Youth Study. JAMA 281, 727-735 (1999).
2. Stary, H. C. The sequence of cell and matrix changes in atherosclerotic lesions of coronary arteries in the first forty years of life. Eur. Heart J. 11 (Suppl. E), 3-19 (1990).
3. Zarins, C. K. et al. Carotid bifurcation atherosclerosis. Quantitative correlation of plaque localization with flow velocity profiles and wall shear stress. Circ. Res. 53, 502-514 (1983).
4. Kwak, B. R. et al. Biomechanical factors in atherosclerosis: mechanisms and clinical implications. Eur. Heart J. 35, 3013-3020 (2014).
5. Bjorkerud, S. & Bondjers, G. Endothelial integrity and viability in the aorta of the normal rabbit and rat as evaluated with dye exclusion tests and interference contrast microscopy. Atherosclerosis 15, 285-300 (1972).
6. Hansson, G. K. & Schwartz, S. M. Evidence for cell death in the vascular endothelium in vivo and in vitro. Am. J. Pathol. 112, 278-286 (1983).
7. Sakao, S. et al. Initial apoptosis is followed by increased proliferation of apoptosis-resistant endothelial cells. FASEB J. 19, 1178-1180 (2005).
8. Tardy, Y., Resnick, N., Nagel, T., Gimbrone, M. A. Jr & Dewey, C. F. Jr. Shear stress gradients remodel endothelial monolayers in vitro via a cell proliferation-migration-loss cycle. Arterioscler. Thromb. Vasc. Biol. 17, 3102-3106 (1997).
9. Hajra, L. et al. The NF-κB signal transduction pathway in aortic endothelial cells is primed for activation in regions predisposed to atherosclerotic lesion formation. Proc. Natl Acad. Sci. USA 97, 9052-9057 (2000).
10. Jongstra-Bilen, J. et al. Low-grade chronic inflammation in regions of the normal mouse arterial intima predisposed to atherosclerosis. J. Exp. Med. 203, 2073-2083 (2006).
11. Warboys, C. M. et al. Disturbed flow promotes endothelial senescence via a p53-dependent pathway. Arterioscler. Thromb. Vasc. Biol. 34, 985-995 (2014).
12. Lin, S. J., Jan, K. M. & Chien, S. Role of dying endothelial cells in transendothelial macromolecular transport. Arteriosclerosis 10, 703-709 (1990).
13. Foteinos, G., Hu, Y., Xiao, Q., Metzler, B. & Xu, Q. Rapid endothelial turnover in atherosclerosis-prone areas coincides with stem cell repair in apolipoprotein E-deficient mice. Circulation 117, 1856-1863 (2008).
14. Sata, M. & Walsh, K. Oxidized LDL activates fas-mediated endothelial cell apoptosis. J. Clin. Invest. 102, 1682-1689 (1998).
15. Dimmeler, S., Haendeler, J., Galle, J. & Zeiher, A. M. Oxidized low-density lipoprotein induces apoptosis of human endothelial cells by activation of CPP32-like proteases. A mechanistic clue to the 'response to injury' hypothesis. Circulation 95, 1760-1763 (1997).
16. Chen, C. H. et al. Oxidized low-density lipoproteins inhibit endothelial cell proliferation by suppressing basic fibroblast growth factor expression. Circulation 101, 171-177 (2000).
17. Rong, J. X. et al. Arterial injury by cholesterol oxidation products causes endothelial dysfunction and arterial wall cholesterol accumulation. Arterioscler. Thromb. Vasc. Biol. 18, 1885-1894 (1998).
18. Robbins, C. S. et al. Local proliferation dominates lesional macrophage accumulation in atherosclerosis. Nat. Med. 19, 1166-1172 (2013).
19. Huang, S. C. et al. Cell-intrinsic lysosomal lipolysis is essential for alternative activation of macrophages. Nat. Immunol. 15, 846-855 (2014).
20. Ricote, M., Li, A. C., Willson, T. M., Kelly, C. J. & Glass, C. K. The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation. Nature 391, 79-82 (1998).
21. Nagy, L., Tontonoz, P., Alvarez, J. G., Chen, H. & Evans, R. M. Oxidized LDL regulates macrophage gene expression through ligand activation of PPARγ. Cell 93, 229-240 (1998).
22. Zhou, J., Lhotak, S., Hilditch, B. A. & Austin, R. C. Activation of the unfolded protein response occurs at all stages of atherosclerotic lesion development in apolipoprotein E-deficient mice. Circulation 111, 1814-1821 (2005).
23. Sun, Y. et al. Free cholesterol accumulation in macrophage membranes activates Toll-like receptors and p38 mitogen-activated protein kinase and induces cathepsin K. Circ. Res. 104, 455-465 (2009).
24. Fessler, M. B. & Parks, J. S. Intracellular lipid flux and membrane microdomains as organizing principles in inflammatory cell signaling. J. Immunol. 187, 1529-1535 (2011).
25. Yvan-Charvet, L. et al. Increased inflammatory gene expression in ABC transporter-deficient macrophages: free cholesterol accumulation, increased signaling via toll-like receptors, and neutrophil infiltration of atherosclerotic lesions. Circulation 118, 1837-1847 (2008).
26. Zhu, X. et al. Increased cellular free cholesterol in macrophage-specific Abca1 knock-out mice enhances pro-inflammatory response of macrophages. J. Biol. Chem. 283, 22930-22941 (2008).
27. Zhu, X. et al. Macrophage ABCA1 reduces MyD88-dependent Toll-like receptor trafficking to lipid rafts by reduction of lipid raft cholesterol. J. Lipid Res. 51, 3196-3206 (2010).
28. Shenderov, K. et al. Cutting edge: Endoplasmic reticulum stress licenses macrophages to produce mature IL-1β in response to TLR4 stimulation through a caspase-8-and TRIF-dependent pathway. J. Immunol. 192, 2029-2033 (2014).
29. Seimon, T. A. et al. Atherogenic lipids and lipoproteins trigger CD36-TLR2-dependent apoptosis in macrophages undergoing endoplasmic reticulum stress. Cell Metab. 12, 467-482 (2010).
30. Tabas, I. Macrophage death and defective inflammation resolution in atherosclerosis. Nat. Rev. Immunol. 10, 36-46 (2010).
31. Nazari-Jahantigh, M., Wei, Y. & Schober, A. The role of microRNAs in arterial remodelling. Thromb. Haemost. 107, 611-618 (2012).
32. Fernandez-Hernando, C., Ramirez, C. M., Goedeke, L. & Suarez, Y. MicroRNAs in metabolic disease. Arterioscler. Thromb. Vasc. Biol. 33, 178-185 (2013).
33. Norata, G. D., Sala, F., Catapano, A. L. & Fernandez-Hernando, C. MicroRNAs and lipoproteins: a connection beyond atherosclerosis? Atherosclerosis 227, 209-215 (2013).
34. Rayner, K. J. & Hennessy, E. J. Extracellular communication via microRNA: lipid particles have a new message. J. Lipid Res. 54, 1174-1181 (2013).
35. Wei, Y., Schober, A. & Weber, C. Pathogenic arterial remodeling: the good and bad of microRNAs. Am. J. Physiol. Heart Circ. Physiol. 304, H1050-H1059 (2013).
36. Parmar, K. M. et al. Integration of flow-dependent endothelial phenotypes by Krüppel-like factor 2. J. Clin. Invest. 116, 49-58 (2006).
37. Atkins, G. B. & Jain, M. K. Role of Krüppel-like transcription factors in endothelial biology. Circ. Res. 100, 1686-1695 (2007).
38. Dai, G. et al. Biomechanical forces in atherosclerosis-resistant vascular regions regulate endothelial redox balance via phosphoinositol 3-kinase/Akt-dependent activation of Nrf2. Circ. Res. 101, 723-733 (2007).
39. Zakkar, M. et al. Activation of Nrf2 in endothelial cells protects arteries from exhibiting a proinflammatory state. Arterioscler. Thromb. Vasc. Biol. 29, 1851-1857 (2009).
40. Abe, J. & Berk, B. C. Novel mechanisms of endothelial mechanotransduction. Arterioscler. Thromb. Vasc. Biol. 34, 2378-2386 (2014).
41. Doddaballapur, A. et al. Laminar shear stress inhibits endothelial cell metabolism via KLF2-mediated repression of PFKFB3. Arterioscler. Thromb. Vasc. Biol. 35, 137-145 (2015).
42. Le, N. T. et al. A crucial role for p90RSK-mediated reduction of ERK5 transcriptional activity in endothelial dysfunction and atherosclerosis. Circulation 127, 486-499 (2013).
43. Ohnesorge, N. et al. Erk5 activation elicits a vasoprotective endothelial phenotype via induction of Krüppel-like factor 4 (KLF4). J. Biol. Chem. 285, 26199-26210 (2010).
44. Zhou, G. et al. Endothelial Krüppel-like factor 4 protects against atherothrombosis in mice. J. Clin. Invest. 122, 4727-4731 (2012).
45. Hamik, A. et al. Krüppel-like factor 4 regulates endothelial inflammation. J. Biol. Chem. 282, 13769-13779 (2007).
46. Dimmeler, S., Assmus, B., Hermann, C., Haendeler, J. & Zeiher, A. M. Fluid shear stress stimulates phosphorylation of Akt in human endothelial cells: involvement in suppression of apoptosis. Circ. Res. 83, 334-341 (1998).
47. Shay-Salit, A. et al. VEGF receptor 2 and the adherens junction as a mechanical transducer in vascular endothelial cells. Proc. Natl Acad. Sci. USA 99, 9462-9467 (2002).
48. Iurlaro, M. et al. VE-cadherin expression and clustering maintain low levels of survivin in endothelial cells. Am. J. Pathol. 165, 181-189 (2004).
49. Gelfand, B. D. et al. Hemodynamic activation of β-catenin and T-cell-specific transcription factor signaling in vascular endothelium regulates fibronectin expression. Arterioscler. Thromb. Vasc. Biol. 31, 1625-1633 (2011).
50. Grazia Lampugnani, M. et al. Contact inhibition of VEGF-induced proliferation requires vascular endothelial cadherin, β-catenin, and the phosphatase DEP-1/CD148. J. Cell Biol. 161, 793-804 (2003).
51. Akimoto, S., Mitsumata, M., Sasaguri, T. & Yoshida, Y. Laminar shear stress inhibits vascular endothelial cell proliferation by inducing cyclin-dependent kinase inhibitor p21 (Sdi1/Cip1/Waf1). Circ. Res. 86, 185-190 (2000).
52. Lin, K. et al. Molecular mechanism of endothelial growth arrest by laminar shear stress. Proc. Natl Acad. Sci. USA 97, 9385-9389 (2000).
53. Ando, J., Nomura, H. & Kamiya, A. The effect of fluid shear stress on the migration and proliferation of cultured endothelial cells. Microvasc. Res. 33, 62-70 (1987).
54. Vyalov, S., Langille, B. L. & Gotlieb, A. I. Decreased blood flow rate disrupts endothelial repair in vivo. Am. J. Pathol. 149, 2107-2118 (1996).
55. Hansson, G. K., Chao, S., Schwartz, S. M. & Reidy, M. A. Aortic endothelial cell death and replication in normal and lipopolysaccharide-treated rats. Am. J. Pathol. 121, 123-127 (1985).
56. Civelek, M., Manduchi, E., Riley, R. J., Stoeckert, C. J. Jr & Davies, P. F. Chronic endoplasmic reticulum stress activates unfolded protein response in arterial endothelium in regions of susceptibility to atherosclerosis. Circ. Res. 105, 453-461 (2009).
57. Feaver, R. E., Hastings, N. E., Pryor, A. & Blackman, B. R. GRP78 upregulation by atheroprone shear stress via p38-, a-dependent mechanism in endothelial cells. Arterioscler. Thromb. Vasc. Biol. 28, 1534-1541 (2008).
58. Zeng, L. et al. Sustained activation of XBP1 splicing leads to endothelial apoptosis and atherosclerosis development in response to disturbed flow. Proc. Natl Acad. Sci. USA 106, 8326-8331 (2009).
59. Chaudhury, H. et al. c-Jun N-terminal kinase primes endothelial cells at atheroprone sites for apoptosis. Arterioscler. Thromb. Vasc. Biol. 30, 546-553 (2010).
60. Cuhlmann, S. et al. Disturbed blood flow induces RelA expression via c-Jun N-terminal kinase 1: a novel mode of NF-KB regulation that promotes arterial inflammation. Circ. Res. 108, 950-959 (2011).
61. Tzima, E. et al. A mechanosensory complex that mediates the endothelial cell response to fluid shear stress. Nature 437, 426-431 (2005).
62. Partridge, J. et al. Laminar shear stress acts as a switch to regulate divergent functions of NF-KB n endothelial cells. FASEB J. 21, 3553-3561 (2007).
63. Gareus, R. et al. Endothelial cell-specific NF-KB nhibition protects mice from atherosclerosis. Cell Metab. 8, 372-383 (2008).
64. Hasegawa, Y. et al. Blockade of the nuclear factor-KB pathway in the endothelium prevents nsulin resistance and prolongs life spans. Circulation 125, 1122-1133 (2012).
65. Boekholdt, S. M. et al. Very low levels of atherogenic lipoproteins and the risk for cardiovascular events: a meta-analysis of statin trials. J. Am. Coll. Cardiol. 64, 485-494 (2014).
66. McCullagh, K. G. Arteriosclerosis in the African elephant. I. Intimal atherosclerosis and its possible causes. Atherosclerosis 16, 307-335 (1972).
67. Thompson, R. C. et al. Atherosclerosis across 4, 000 years of human history: the Horus study of four ancient populations. Lancet 381, 1211-1222 (2013).
68. Harris, T. A., Yamakuchi, M., Ferlito, M., Mendell, J. T. & Lowenstein, C. J. MicroRNA-126 regulates endothelial expression of vascular cel adhesion molecule 1. Proc. Natl Acad. Sci. USA 105, 1516-1521 (2008).
69. Qin, X. et al. MicroRNA-19a mediates the suppressive effect of laminar flow on cyclin D1 expression in human umbilical vein endothelial cells. Proc. Natl Acad. Sci. USA 107, 3240-3244 (2010).
70. Wang, K. C. et al. Role of microRNA-23b in flow-regulation of Rb phosphorylation and endothelial cell growth. Proc. Natl Acad. Sci. USA 107, 3234-3239 (2010).
71. Son, D. J. et al. The atypical mechanosensitive microRNA-712 derived from pre-ribosomal RNA induces endothelial inflammation and atherosclerosis. Nat. Commun. 4, 3000 (2013).
72. Hergenreider, E. et al. Atheroprotective communication between endothelial cells and smooth muscle cells through miRNAs. Nat. Cell Biol. 14, 249-256 (2012).
73. Wang, K. C. et al. MicroRNA-23b regulates cyclin-dependent kinase-activating kinase complex through cyclin H repression to modulate endothelial transcription and growth under flow. Arterioscler. Thromb. Vasc. Biol. 34, 1437-1445 (2014).
74. Fang, Y., Shi, C., Manduchi, E., Civelek, M. & Davies, P. F. MicroRNA-10a regulation of proinflammatory phenotype in athero-susceptible endothelium in vivo and in vitro. Proc. Natl Acad. Sci. USA 107, 13450-13455 (2010).
75. Loyer, X. et al. Inhibition of microRNA-92a prevents endothelial dysfunction and atherosclerosis in mice. Circ. Res. 114, 434-443 (2014).
76. Wang, C. et al. TAK1 is a ubiquitin-dependent kinase of MKK and IKK. Nature 412, 346-351 (2001).
77. Spiegelman, V. S. et al. Induction of β-transducin repeat-containing protein by JNK signaling and its role in the activation of NF-κB. J. Biol. Chem. 276, 27152-27158 (2001).
78. Wu, C. & Ghosh, S. β-TrCP mediates the signal-induced ubiquitination of IκBβ. J. Biol. Chem. 274, 29591-29594 (1999).
79. Sun, X. et al. Systemic delivery of microRNA-181b inhibits nuclear factor-κB activation, vascular inflammation, and atherosclerosis in apolipoprotein E-deficient mice. Circ. Res. 114, 32-40 (2014).
80. Sun, X. et al. MicroRNA-181b regulates NF-κB-mediated vascular inflammation. J. Clin. Invest. 122, 1973-1990 (2012).
81. Zhou, J. et al. MicroRNA-21 targets peroxisome proliferators-activated receptor-alpha in an autoregulatory loop to modulate flow-induced endothelial inflammation. Proc. Natl Acad. Sci. USA 108, 10355-10360 (2011).
82. Wu, W. et al. Flow-dependent regulation of Krüppel-like factor 2 is mediated by microRNA-92a. Circulation 124, 633-641 (2011).
83. Fang, Y. & Davies, P. F. Site-specific microRNA-92a regulation of Krüppel-like factors 4 and 2 in atherosusceptible endothelium. Arterioscler. Thromb. Vasc. Biol. 32, 979-987 (2012).
84. Ni, C. W., Hsieh, H. J., Chao, Y. J. & Wang, D. L. Interleukin-6-induced JAK2/STAT3 signaling pathway in endothelial cells is suppressed by hemodynamic flow. Am. J. Physiol. Cell Physiol. 287, C771-C780 (2004).
85. Schmitt, M. M. et al. Endothelial junctional adhesion molecule-a guides monocytes into flow-dependent predilection sites of atherosclerosis. Circulation 129, 66-76 (2014).
86. Bosse, G. D. et al. The decapping scavenger enzyme DCS-1 controls microRNA levels in Caenorhabditis elegans. Mol. Cell 50, 281-287 (2013).
87. Orban, T. I. & Izaurralde, E. Decay of mRNAs targeted by RISC requires XRN1, the Ski complex, and the exosome. RNA 11, 459-469 (2005).
88. Ni, C. W., Qiu, H. & Jo, H. MicroRNA-663 upregulated by oscillatory shear stress plays a role in inflammatory response of endothelial cells. Am. J. Physiol. Heart Circ. Physiol. 300, H1762-H1769 (2011).
89. Daniel, J.-M. et al. Inhibition of miR-92a improves re-endothelialization and prevents neointima formation following vascular injury. Cardiovasc. Res. 103, 564-572 (2014).
90. Iaconetti, C. et al. Inhibition of miR-92a increases endothelial proliferation and migration in vitro as well as reduces neointimal proliferation in vivo after vascular injury. Basic Res. Cardiol. 107, 296 (2012).
91. Fan, W. et al. Shear-sensitive microRNA-34a modulates flow-dependent regulation of endothelial inflammation. J. Cell Sci. 128, 70-80 (2015).
92. Ito, T., Yagi, S. & Yamakuchi, M. MicroRNA-34a regulation of endothelial senescence. Biochem. Biophys. Res. Commun. 398, 735-740 (2010).
93. Menghini, R. et al. MicroRNA 217 modulates endothelial cell senescence via silent information regulator 1. Circulation 120, 1524-1532 (2009).
94. Gracia-Sancho, J., Villarreal, G. Jr, Zhang, Y. & Garcia-Cardena, G. Activation of SIRT1 by resveratrol induces KLF2 expression conferring an endothelial vasoprotective phenotype. Cardiovasc. Res. 85, 514-519 (2010).
95. Yeung, F. et al. Modulation of NF-κB-dependent transcription and cell survival by the SIRT1 deacetylase. EMBO J. 23, 2369-2380 (2004).
96. Zu, Y. et al. SIRT1 promotes proliferation and prevents senescence through targeting LKB1 in primary porcine aortic endothelial cells. Circ. Res. 106, 1384-1393 (2010).
97. Cancel, L. M. & Tarbell, J. M. The role of apoptosis in LDL transport through cultured endothelial cell monolayers. Atherosclerosis 208, 335-341 (2010).
98. Gardner, G., Banka, C. L., Roberts, K. A., Mullick, A. E. & Rutledge, J. C. Modified LDL-mediated increases in endothelial layer permeability are attenuated with 17β-estradiol. Ar terioscler. Thromb. Vasc. Biol. 19, 854-861 (1999).
99. Cominacini, L. et al. Oxidized low density lipoprotein (ox-LDL) binding to ox-LDL receptor-1 in endothelial cells induces the activation of NF-κB through an increased production of intracellular reactive oxygen species. J. Biol. Chem. 275, 12633-12638 (2000).
100. Hong, D. et al. Ox-LDL induces endothelial cell apoptosis via the LOX-1-dependent endoplasmic reticulum stress pathway. Atherosclerosis 235, 310-317 (2014).
101. Bao, M. H., Zhang, Y. W., Lou, X. Y., Cheng, Y. & Zhou, H. H. Protective effects of let-7a and let-7b on oxidized low-density lipoprotein induced endothelial cell injuries. PLoS ONE 9, e106540 (2014).
102. Chen, K. C. et al. Negative feedback regulation between microRNA let-7g and the oxLDL receptor LOX-1. J. Cell Sci. 124, 4115-4124 (2011).
103. Pasquinelli, A. E. et al. Conservation of the sequence and temporal expression of let-7 heterochronic regulatory RNA. Nature 408, 86-89 (2000).
104. Liao, Y. C. et al. Let-7g improves multiple endothelial functions through targeting transforming growth factor-β and SIRT-1 signaling. J. Am. Coll. Cardiol. 63, 1685-1694 (2014).
105. Voellenkle, C. et al. Deep-sequencing of endothelial cells exposed to hypoxia reveals the complexity of known and novel microRNAs. RNA 18, 472-484 (2012).
106. Schober, A. et al. MicroRNA-126-5p promotes endothelial proliferation and limits atherosclerosis by suppressing Dlk1. Nat. Med. 20, 368-376 (2014).
107. Sul, H. S. Minireview: Pref-1: role in adipogenesis and mesenchymal cell fate. Mol. Endocrinol. 23, 1717-1725 (2009).
108. Falix, F. A., Aronson, D. C., Lamers, W. H. & Gaemers, I. C. Possible roles of DLK1 in the Notch pathway during development and disease. Biochim. Biophys. Acta 1822, 988-995 (2012).
109. Rodriguez, P. et al. The non-canonical NOTCH ligand DLK1 exhibits a novel vascular role as a strong inhibitor of angiogenesis. Cardiovasc. Res. 93, 232-241 (2012).
110. Fish, J. E. et al. miR-126 regulates angiogenic signaling and vascular integrity. Dev. Cell 15, 272-284 (2008).
111. Wang, S. et al. The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis. Dev. Cell 15, 261-271 (2008).
112. Wang, Y. et al. MicroRNA-126 attenuates palmitate-induced apoptosis by targeting TRAF7 in HUVECs. Mol. Cell. Biochem. 399, 123-130 (2015).
113. Zernecke, A. et al. Delivery of microRNA-126 by apoptotic bodies induces CXCL12-dependent vascular protection. Sci. Signal. 2, ra81 (2009).
114. Jansen, F. et al. Endothelial microparticle-mediated transfer of microRNA-126 promotes vascular endothelial cell repair via SPRED1 and is abrogated in glucose-damaged endothelial microparticles. Circulation 128, 2026-2038 (2013).
115. van der Pol, E., Boing, A. N., Harrison, P., Sturk, A. & Nieuwland, R. Classification, functions, and clinical relevance of extracellular vesicles. Pharmacol. Rev. 64, 676-705 (2012).
116. Sirois, I. et al. Caspase-3-dependent export of TCTP: a novel pathway for antiapoptotic intercellular communication. Cell Death Differ. 18, 549-562 (2011).
117. Villarroya-Beltri, C. et al. Sumoylated hnRNPA2B1 controls the sorting of miRNAs into exosomes through binding to specific motifs. Nat. Commun. 4, 2980 (2013).
118. Squadrito, M. L. et al. Endogenous RNAs modulate microRNA sorting to exosomes and transfer to acceptor cells. Cell Rep. 8, 1432-1446 (2014).
119. Zampetaki, A. et al. Plasma microRNA profiling reveals loss of endothelial miR-126 and other microRNAs in type 2 diabetes. Circ. Res. 107, 810-817 (2010).
120. Wei, Y., Nazari-Jahantigh, M., Neth, P., Weber, C. & Schober, A. MicroRNA-126,-145, and-155: a therapeutic triad in atherosclerosis? Ar terioscler. Thromb. Vasc. Biol. 33, 449-454 (2013).
121. Noels, H. et al. Deficiency of endothelial Cxcr4 reduces reendothelialization and enhances neointimal hyperplasia after vascular injury in atherosclerosis-prone mice. Arterioscler. Thromb. Vasc. Biol. 34, 1209-1220 (2014).
122. Ceradini, D. J. et al. Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat. Med. 10, 858-864 (2004).
123. Akhtar, S., Gremse, F., Kiessling, F., Weber, C. & Schober, A. CXCL12 promotes the stabilization of atherosclerotic lesions mediated by smooth muscle progenitor cells in Apoe-deficient mice. Ar terioscler. Thromb. Vasc. Biol. 33, 679-686 (2013).
124. - progenitor cells in ischaemia. Cardiovasc. Res. 92, 449-455 (2011).
125. Zhou, J. et al. Regulation of vascular smooth muscle cell turnover by endothelial cell-secreted microRNA-126: role of shear stress. Circ. Res. 113, 40-51 (2013).
126. Mukai, Y. et al. Decreased vascular lesion formation in mice with inducible endothelial-specific expression of protein kinase Akt. J. Clin. Invest. 116, 334-343 (2006).
127. Cheng, Y. et al. MicroRNA-145, a novel smooth muscle cell phenotypic marker and modulator, controls vascular neointimal lesion formation. Circ. Res. 105, 158-166 (2009).
128. Xin, M. et al. MicroRNAs miR-143 and miR-145 modulate cytoskeletal dynamics and responsiveness of smooth muscle cells to injury. Genes Dev. 23, 2166-2178 (2009).
129. Zhao, N. et al. MicroRNA miR145 regulates TGFBR2 expression and matrix synthesis in vascular smooth muscle cells. Circ. Res. 116, 23-34 (2015).
130. Boucher, J. M., Peterson, S. M., Urs, S., Zhang, C. & Liaw, L. The miR-143/145 cluster is a novel transcriptional target of Jagged-1/Notch signaling in vascular smooth muscle cells. J. Biol. Chem. 286, 28312-28321 (2011).
131. Vengrenyuk, Y. et al. Cholesterol loading reprograms the miR-143/145-myocardin axis to convert aortic smooth muscle cells to a dysfunctional macrophage-like phenotype. Ar terioscler. Thromb. Vasc. Biol. 35, 535-546 (2015).
132. Lovren, F. et al. MicroRNA-145 targeted therapy reduces atherosclerosis. Circulation 126, S81-S90 (2012).
133. -/-mice. Thromb. Haemost. 112, 796-802 (2014).
134. Chen, L. J. et al. MicroRNA mediation of endothelial inflammatory response to smooth muscle cells and its inhibition by atheroprotective shear stress. Circ. Res. http://dx.doi.org/10.1161/circresaha.116.305987.
135. Cheng, H. S. et al. MicroRNA-146 represses endothelial activation by inhibiting pro-inflammatory pathways. EMBO Mol. Med. 5, 949-966 (2013).
136. Lawrence, T. & Natoli, G. Transcriptional regulation of macrophage polarization: enabling diversity with identity. Nat. Rev. Immunol. 11, 750-761 (2011).
137. Mantovani, A., Garlanda, C. & Locati, M. Macrophage diversity and polarization in atherosclerosis: a question of balance. Ar terioscler. Thromb. Vasc. Biol. 29, 1419-1423 (2009).
138. Tugal, D., Liao, X. & Jain, M. K. Transcriptional control of macrophage polarization. Arterioscler. Thromb. Vasc. Biol. 33, 1135-1144 (2013).
139. Murray, P. J. & Wynn, T. A. Protective and pathogenic functions of macrophage subsets. Nat. Rev. Immunol. 11, 723-737 (2011).
140. Jenkins, S. J. et al. IL-4 directly signals tissue-resident macrophages to proliferate beyond homeostatic levels controlled by CSF-1. J. Exp. Med. 210, 2477-2491 (2013).
141. Lichtnekert, J., Kawakami, T., Parks, W. C. & Duffield, J. S. Changes in macrophage phenotype as the immune response evolves. Curr. Opin. Pharmacol. 13, 555-564 (2013).
142. Khallou-Laschet, J. et al. Macrophage plasticity in experimental atherosclerosis. PLoS ONE 5, e8852 (2010).
143. Nazari-Jahantigh, M. et al. MicroRNA-155 promotes atherosclerosis by repressing Bcl6 in macrophages. J. Clin. Invest. 122, 4190-4202 (2012).
144. Graff, J. W., Dickson, A. M., Clay, G., McCaffrey, A. P. & Wilson, M. E. Identifying functional microRNAs in macrophages with polarized phenotypes. J. Biol. Chem. 287, 21816-21825 (2012).
145. Dueck, A., Eichner, A., Sixt, M. & Meister, G. A miR-155-dependent microRNA hierarchy in dendritic cell maturation and macrophage activation. FEBS Lett. 588, 632-640 (2014).
146. Du, F. et al. MicroRNA-155 deficiency results in decreased macrophage inflammation and attenuated atherogenesis in apolipoprotein E-deficient mice. Arterioscler. Thromb. Vasc. Biol. 34, 759-767 (2014).
147. Androulidaki, A. et al. The kinase Akt1 controls macrophage response to lipopolysaccharide by regulating microRNAs. Immunity 31, 220-231 (2009).
148. Arranz, A. et al. Akt1 and Akt2 protein kinases differentially contribute to macrophage polarization. Proc. Natl Acad. Sci. USA 109, 9517-9522 (2012).
149. Petrella, B. L. & Brinckerhoff, C. E. PTEN suppression of YY1 induces HIF-2 activity in von-Hippel-Lindau-null renal-cell carcinoma. Cancer Biol. Ther. 8, 1389-1401 (2009).
150. Tian, F. J. et al. Elevated microRNA-155 promotes foam cell formation by targeting HBP1 in atherogenesis. Cardiovasc. Res. 103, 100-110 (2014).
151. Wei, Y. et al. The microRNA-342-5p fosters inflammatory macrophage activation through an Akt1-and microRNA-155-dependent pathway during atherosclerosis. Circulation 127, 1609-1619 (2013).
152. O'Connell, R. M., Chaudhuri, A. A., Rao, D. S. & Baltimore, D. Inositol phosphatase SHIP1 is a primary target of miR-155. Proc. Natl Acad. Sci. USA 106, 7113-7118 (2009).
153. Barish, G. D. et al. Bcl-6 and NF-κB cistromes mediate opposing regulation of the innate immune response. Genes Dev. 24, 2760-2765 (2010).
154. Barish, G. D. et al. The Bcl6-SMRT/NCoR cistrome represses inflammation to attenuate atherosclerosis. Cell Metab. 15, 554-562 (2012).
155. Schober, A. et al. Stabilization of atherosclerotic plaques by blockade of macrophage migration inhibitory factor after vascular injury in apolipoprotein E-deficient mice. Circulation 109, 380-385 (2004).
156. Qin, Z. The use of THP-1 cells as a model for mimicking the function and regulation of monocytes and macrophages in the vasculature. Atherosclerosis 221, 2-11 (2012).
157. Zhu, J. et al. Regulation of microRNA-155 in atherosclerotic inflammatory responses by targeting MAP3K10. PLoS ONE 7, e46551 (2012).
158. Kant, S. et al. TNF-stimulated MAP kinase activation mediated by a Rho family GTPase signaling pathway. Genes Dev. 25, 2069-2078 (2011).
159. Donners, M. M. et al. Hematopoietic miR155 deficiency enhances atherosclerosis and decreases plaque stability in hyperlipidemic mice. PLoS ONE 7, e35877 (2012).
160. Schreyer, S. A., Lystig, T. C., Vick, C. M. & LeBoeuf, R. C. Mice deficient in apolipoprotein E but not LDL receptors are resistant to accelerated atherosclerosis associated with obesity. Atherosclerosis 171, 49-55 (2003).
161. Schreyer, S. A., Vick, C., Lystig, T. C., Mystkowski, P. & LeBoeuf, R. C. LDL receptor but not apolipoprotein E deficiency increases diet-induced obesity and diabetes in mice. Am. J. Physiol. Endocrinol. Metab. 282, E207-E214 (2002).
162. Maegdefessel, L. et al. miR-24 limits aortic vascular inflammation and murine abdominal aneurysm development. Nat. Commun. 5, 5214 (2014).
163. Gong, Z., Xing, S., Zheng, F. & Xing, Q. Increased expression of chitinase 3-like 1 in aorta of patients with atherosclerosis and suppression of atherosclerosis in apolipoprotein E-knockout mice by chitinase 3-like 1 gene silencing. Mediators Inflamm. 2014, 905463 (2014).
164. Boot, R. G. et al. Strong induction of members of the chitinase family of proteins in atherosclerosis: chitotriosidase and human cartilage gp-39 expressed in lesion macrophages. Arterioscler. Thromb. Vasc. Biol. 19, 687-694 (1999).
165. Di Gregoli, K. et al. MicroRNA-24 regulates macrophage behavior and retards atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 34, 1990-2000 (2014).
166. Rosenson, R. S. et al. Cholesterol efflux and atheroprotection: advancing the concept of reverse cholesterol transport. Circulation 125, 1905-1919 (2012).
167. Westerterp, M. et al. ATP-binding cassette transporters, atherosclerosis, and inflammation. Circ. Res. 114, 157-170 (2014).
168. Davalos, A. & Fernandez-Hernando, C. From evolution to revolution: miRNAs as pharmacological targets for modulating cholesterol efflux and reverse cholesterol transport. Pharmacol. Res. 75, 60-72 (2013).
169. Rayner, K. J. et al. MiR-33 contributes to the regulation of cholesterol homeostasis. Science 328, 1570-1573 (2010).
170. Horie, T. et al. MicroRNA-33 encoded by an intron of sterol regulatory element-binding protein 2 (Srebp2) regulates HDL in vivo. Proc. Natl Acad. Sci. USA 107, 17321-17326 (2010).
171. Rayner, K. J. et al. Antagonism of miR-33 in mice promotes reverse cholesterol transport and regression of atherosclerosis. J. Clin. Invest. 121, 2921-2931 (2011).
172. Marquart, T. J., Wu, J., Lusis, A. J. & Baldan, A. Anti-miR-33 therapy does not alter the progression of atherosclerosis in low-density lipoprotein receptor-deficient mice. Arterioscler. Thromb. Vasc. Biol. 33, 455-458 (2013).
173. -/- mice-brief report. Arterioscler. Thromb. Vasc. Biol. 33, 1973-1977 (2013).
174. -/- mice. J. Am. Heart Assoc. 1, e003376 (2012).
175. Distel, E. et al. miR33 inhibition overcomes deleterious effects of diabetes mellitus on atherosclerosis plaque regression in mice. Circ. Res. 115, 759-769 (2014).
176. Ho, P. C., Chang, K. C., Chuang, Y. S. & Wei, L. N. Cholesterol regulation of receptor-interacting protein 140 via microRNA-33 in inflammatory cytokine production. FASEB J. 25, 1758-1766 (2011).
177. Nautiyal, J., Christian, M. & Parker, M. G. Distinct functions for RIP140 in development, inflammation, and metabolism. Trends Endocrinol. Metab. 24, 451-459 (2013).
178. Goedeke, L. et al. A regulatory role for microRNA 33∗ in controlling lipid metabolism gene expression. Mol. Cell. Biol. 33, 2339-2352 (2013).
179. Hu, Y. W. et al. An agomir of miR-144-3p accelerates plaque formation through impairing reverse cholesterol transport and promoting pro-inflammatory cytokine production. PLoS ONE 9, e94997 (2014).
180. Zhang, M. et al. MicroRNA-27a/b regulates cellular cholesterol efflux, influx and esterification/hydrolysis in THP-1 macrophages. Atherosclerosis 234, 54-64 (2014).
181. Lv, Y. C. et al. MicroRNA-19b promotes macrophage cholesterol accumulation and aortic atherosclerosis by targeting ATP-binding cassette transporter A1. Atherosclerosis 236, 215-226 (2014).
182. Ramirez, C. M. et al. MicroRNA-758 regulates cholesterol efflux through posttranscriptional repression of ATP-binding cassette transporter A1. Arterioscler. Thromb. Vasc. Biol. 31, 2707-2714 (2011).
183. Ramirez, C. M. et al. Control of cholesterol metabolism and plasma high-density lipoprotein levels by microRNA-144. Circ. Res. 112, 1592-1601 (2013).
184. Wang, D. et al. Coenzyme Q10 promotes macrophage cholesterol efflux by regulation of the activator protein-1/miR-378/ATP-binding cassette transporter G1-signaling pathway. Arterioscler. Thromb. Vasc. Biol. 34, 1860-1870 (2014).
185. Vinod, M. et al. miR-206 controls LXRα expression and promotes LXR-mediated cholesterol efflux in macrophages. Biochim. Biophys. Acta 1841, 827-835 (2014).
186. O'Brien, K. D., Gordon, D., Deeb, S., Ferguson, M. & Chait, A. Lipoprotein lipase is synthesized by macrophage-derived foam cells in human coronary atherosclerotic plaques. J. Clin. Invest. 89, 1544-1550 (1992).
187. Takahashi, M. et al. Macrophage lipoprotein lipase modulates the development of atherosclerosis but not adiposity. J. Lipid Res. 54, 1124-1134 (2013).
188. Pentikainen, M. O., Oksjoki, R., Oorni, K. & Kovanen, P. T. Lipoprotein lipase in the arterial wall: linking LDL to the arterial extracellular matrix and much more. Arterioscler. Thromb. Vasc. Biol. 22, 211-217 (2002).
189. Seo, T. et al. Lipoprotein lipase-mediated selective uptake from low density lipoprotein requires cell surface proteoglycans and is independent of scavenger receptor class B type 1. J. Biol. Chem. 275, 30355-30362 (2000).
190. Tian, G. P. et al. MicroRNA-467b targets LPL gene in RAW 264.7 macrophages and attenuates lipid accumulation and proinflammatory cytokine secretion. Biochimie 94, 2749-2755 (2012).
191. Tian, G. P. et al. The effects of miR-467b on lipoprotein lipase (LPL) expression, pro-inflammatory cytokine, lipid levels and atherosclerotic lesions in apolipoprotein E knockout mice. Biochem. Biophys. Res. Commun. 443, 428-434 (2014).
192. Helwak, A., Kudla, G., Dudnakova, T. & Tollervey, D. Mapping the human miRNA interactome by CLASH reveals frequent noncanonical binding. Cell 153, 654-665 (2013).